Predictive value of sGaw, FEF25 - 75, and FEV1 for development of asthma after a negative methacholine challenge test

Journal of Asthma

Volumn 46, Issue 3, 2009, Pages 284-290

  Khalid, Imran ^a   Obeid, Imad ^a   Digiovine, Bruno ^a   Khalid, Usama ^b   Morris, Zachary Q ^a  

^a HENRY FORD HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN DEARBORN   (United States)

Author keywords

Asthma; Forced expiratory volume in 1 seconds (FEV1); Forced mid expiratory flow (FEF25 75); Methacholine challenge test; Specific conductance (sGaw)

Indexed keywords

METHACHOLINE; METHACHOLINE CHLORIDE; DIAGNOSTIC AGENT;

ADULT; ARTICLE; ASTHMA; BODY PLETHYSMOGRAPHY; CLINICAL ARTICLE; CONDUCTANCE; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DOSIMETRY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PREDICTION; PREDICTION AND FORECASTING; PROVOCATION TEST; SPECIFIC CONDUCTANCE; SPIROMETRY; SYMPTOM; INHALATION TEST; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

ASTHMA; BRONCHIAL PROVOCATION TESTS; FEMALE; HUMANS; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES;

EID: 65449189547     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900802660980     Document Type: Article

References (26)

1. Bussamra MH, Cukier A, Stelmach R, Rodrigues JC. Evaluation of the magnitude of the bronchodilator response in children and adolescents with asthma. Chest 2005; 127:530-535.
2. Parker AL, McCool D. Pulmonary function characteristics in patients with different patterns of methacholine airway hyperresponsiveness. Chest 2002;121:1818-1823.
3. Bjermer L. History and future perspectives of treating asthma as a systemic and small airways disease. Respir Med 2001; 95:703-719.
4. Cirillo I, Klersy C, Marseglia GL, Vizzaccaro A, Pallestrini E, Tosca M, Ciprandi G. Role of FEF25%-75% as a predictor of bronchial hyperreac-tivity in allergic patients. Ann Allergy Asthma Immunol 2006; 96: 692-700.
5. Lipworth BJ, Clark DJ. Effects of airway calibre on lung delivery of nebulised salbutamol. Thorax 1997; 52:1036-1039.
6. Bahçeciler NN, Barlan IB, Nuhoǧlu Y, Başran MM. Risk factors for the persistence of respiratory symptoms in childhood asthma. Ann Allergy Asthma Immunol 2001; 86:449-455.
7. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ. Guidelines for Methacholine and Exercise Challenge Testing-1999. Am J Respir Crit Care Med January;161: 309-329.
8. Houghton CM, Woodcock AA , Singh D. A comparison of plethysmog-raphy, spirometry and oscillometry for assessing the pulmonary effects of inhaled ipratropium bromide in healthy subjects and patients with asthma. Br J Clin Pharmacol 2005; 59:152-159.
9. Möller GM, Overbeek SE, van Helden-Meeuwsen CG, Hoogsteden HC, Bogaard JM. Eosinophils in the bronchial mucosa in relation to methacholine dose-response curves in atopic asthma. J Appl Physiol 1999; 86: 1352-1356.
10. 25-75 as an early marker of bronchial impairment in patients with seasonal allergic rhinitis. Am J Rhinol 2006; 20:. 641-647.
11. Cirillo I, Klersy C, Marseglia GL, Vizzaccaro A, Pallestrini E, Tosca M, Ciprandi G. Role of FEF25%-75% as a predictor of bronchial hyperreactivity in allergic patients. Ann Allergy Asthma Immunol 2006; 96: 692-700.
12. Fonseca-Guedes CH, Cabral AL, Martins MA. Exercise-induced bron-chospasm in children: comparison of FEV1 and FEF25-75% responses. Pediatr Pulmonol 2003; 36:49-54.
13. Goldstein MF, Pacana SM, Dvorin DJ, Dunsky EH. Retrospective analyses of methacholine inhalation challenges. Chest 1994; 105:1082-1088.
14. Laprise C, Boulet LP. Asymptomatic airway hyperresponsiveness: A three-year follow-up. Am J Respir Crit Care Med 1997;156:403-409.
15. Zhong NS, Chen RC, Yang MO, Wu ZY, Zheng JP, Li YF. Is asymptomatic bronchial hyperresponsiveness an indication of potential asthma? A two-year follow-up of young students with bronchial hyperresponsiveness. Chest 1992; 102:1104-1109.
16. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136.
17. European Thoracic Society. Standardized lung function testing: official statement of the European Respiratory Society. Eur Respir J 1993; 6(suppl 16):1-100.
18. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. AmRev Respir Dis 1981; 123:659-664.
19. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144:1202-1218.
20. Allen ND, Davis BE, Hurst TS, Cockcroft DW. Difference between dosimeter and tidal breathing methacholine challenge: contributions of dose and deep inspiration bronchoprotection. Chest 2005; 128:4018-4023.
21. Cockcroft DW, Davis BE, Todd DC, Smycniuk AJ. Methacholine challenge: comparison of two methods. Chest 2005; 127:839-844.
22. Larbanois A, Delwiche JP, Jamart J, Vandenplas O. Comparison of FEV1 and specific airway conductance in assessing airway response to occupational agents. Allergy 2003; 58:1256-1260.
23. Broeders ME, Molema J, Hop WC, Folgering HT. Bronchial challenge, assessed with forced expiratory maneuvers and airway impedance. Respir Med 2005; 99:1046-1052.
24. Boskabady MH, Farhadi H. Relation of airway responsiveness to salbu-tamol and to methacholine in smokers. Med Sci Monit 2005; 11:CR344-350.
25. Ulrik CS, Søes-Petersen U, Backer V, Lange P, Harving H, Plaschke P. Disease variability in asthma: how do the patients respond?-and why? J Asthma 2008; 45:507-511.
26. 26. Hopp RJ, Biven RA, Degan JA, Bewtra AK, Nair NM, Townley RG. Longitudinal measurement of airway hyperresponsiveness in selected subjects with persisting pulmonary symptoms. J Asthma 1994; 31: 177-186.